The government on Wednesday approved the procurement of 1,50,000 units of 'Oxycare' system developed by the Defence Research and Development Organisation (DRDO) to help in the treatment of COVID-19 patients.
Oxycare is an oxygen supply system based on SpO2 (oxygen saturation) level. The DRDO has already transferred the technology to multiple industries in India for large-scale production of the Oxycare system.
The 'Oxycare' systems will be procured for Rs 322.5 crore using the PM-Cares Fund, according to the defence ministry.
"PM-Cares Fund has accorded sanction for procurement of 1,50,000 units of 'Oxycare' system developed by the DRDO at a cost of Rs 322.5 crore," it said.
The ministry said 1,00,000 manual and 50,000 automatic Oxycare systems are being procured.
"The Oxycare system delivers supplemental oxygen based on the SpO2 levels and prevents a person from sinking into a state of hypoxia which can be fatal," the ministry said in a statement.
Oxycare was developed by the DRDO's Bengaluru-based Defence Bio-Engineering and Electro Medical Laboratory (DEBEL) for soldiers posted at extreme high-altitude areas.
"The system is indigenously developed for operation in field conditions and is robust. It can be effectively used to treat COVID-19 patients," the ministry said.
It said the variants of the system have been configured.
"The basic version consists of a 10-litre oxygen cylinder, a pressure regulator cum flow controller, a humidifier and a nasal cannula. The oxygen flow is regulated manually based on the SpO2 readings," the ministry said.
"In the second configuration, the oxygen cylinder is equipped with electronic controls which automatically regulate the oxygen flow through a low-pressure regulator and an SpO2 probe," it said.
Various parts of India have been ravaged by a devastating second wave of coronavirus pandemic. One of the most common complications being faced by the COVID-19 patients has been a drop in oxygen levels.
The huge surge in coronavirus cases has triggered a shortage of medical oxygen across the country.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)